Ping An Biomedical Co., Ltd. PASW

Set alert

Price alert · PASW

All alert types
5.12 USD -0.26 -4.92%

At close · Oct 30

5.12 0.00 0.00%

After hours · Oct 30, 4:00 PM ET

Bid
5.11 × 17
Ask
5.20 × 1
4.32 Day range 5.53
3.68 52-week range 30.12
YTD
-74.50%
1 year
-83.00%
Open
5.53
Prev close
5.39
Mkt cap
16.01M
Vol
62.32K
Avg vol
165.89K
EPS
-2.38
P/E
0.00
Div yield
0.00%
More statistics
Low
4.32
High
5.53

5D chart

Chart tools
Interval

Chart is warming up

The five-day price history for PASW has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

16.07 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

2 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

C+2 / 5 overall

  • DCF 1
  • Return on Equity 1
  • Return on Assets 1
  • Debt / Equity 4
  • P/E 1
  • P/B 5

Valuation

P/E -12.8×
FY 2021: 20.0×FY 2022: 24.0×FY 2023: -178×FY 2024: -116×FY 2025: -12.8×
FY 2021 5y median -12.8× FY 2025
P/S 4.8×
FY 2021: 1.1×FY 2022: 1.5×FY 2023: 2.1×FY 2024: 1.7×FY 2025: 4.8×
FY 2021 5y median 1.7× FY 2025
P/B 3.6×
FY 2021: -50.7×FY 2022: 37.4×FY 2023: -30.1×FY 2024: -20.7×FY 2025: 3.6×
FY 2021 5y median -20.7× FY 2025
P/FCF -25.4×
FY 2021: -3.3×FY 2022: 8.2×FY 2023: -29.0×FY 2024: 10.2×FY 2025: -25.4×
FY 2021 5y median -3.3× FY 2025
EV/EBITDA -12.0×
FY 2021: 13.9×FY 2022: 18.4×FY 2023: 121×FY 2024: 4870×FY 2025: -12.0×
FY 2021 5y median 18.4× FY 2025
EV/Sales 5.0×
FY 2021: 1.3×FY 2022: 1.8×FY 2023: 2.7×FY 2024: 1.8×FY 2025: 5.0×
FY 2021 5y median 1.8× FY 2025
FCF Yield -3.9%
FY 2021: -30.0%FY 2022: 12.2%FY 2023: -3.4%FY 2024: 9.8%FY 2025: -3.9%
FY 2021 5y median -3.4% FY 2025

Profitability

Gross Margin 2.8%
FY 2021: 14.3%FY 2022: 12.3%FY 2023: 5.1%FY 2024: 6.2%FY 2025: 2.8%
FY 2021 5y median 6.2% FY 2025
Operating Margin -43.1%
FY 2021: 8.3%FY 2022: 9.4%FY 2023: 0.7%FY 2024: -0.0%FY 2025: -43.1%
FY 2021 5y median 0.7% FY 2025
Net Margin -37.6%
FY 2021: 5.2%FY 2022: 6.3%FY 2023: -1.2%FY 2024: -1.5%FY 2025: -37.6%
FY 2021 5y median -1.2% FY 2025
ROE -28.4%
FY 2021: -252.8%FY 2022: 157.1%FY 2023: 17.0%FY 2024: 17.9%FY 2025: -28.4%
FY 2021 5y median 17.0% FY 2025
ROIC -23.1%
FY 2021: 20.5%FY 2022: 20.2%FY 2023: -39.4%FY 2024: -0.1%FY 2025: -23.1%
FY 2021 5y median -0.1% FY 2025
ROA -18.8%
FY 2021: 7.1%FY 2022: 8.8%FY 2023: -1.2%FY 2024: -2.3%FY 2025: -18.8%
FY 2021 5y median -1.2% FY 2025

Growth (YoY)

Revenue -61.0%
FY 2021: 0.0%FY 2022: 15.1%FY 2023: -27.9%FY 2024: 6.1%FY 2025: -61.0%
FY 2021 FY 2025
Operating Income -720913.7%
FY 2021: 0.0%FY 2022: 30.8%FY 2023: -94.3%FY 2024: -100.3%FY 2025: -720913.7%
FY 2021 FY 2025
EPS (diluted) -867.7%
FY 2021: 0.0%FY 2022: -7.9%FY 2023: -113.9%FY 2024: -47.0%FY 2025: -867.7%
FY 2021 FY 2025
Free Cash Flow -143.9%
FY 2021: 0.0%FY 2022: 167.1%FY 2023: -128.9%FY 2024: 340.5%FY 2025: -143.9%
FY 2021 FY 2025

Financial Health

Current Ratio 2.8×
FY 2021: 0.9×FY 2022: 1.0×FY 2023: 0.9×FY 2024: 0.8×FY 2025: 2.8×
FY 2021 5y median 0.9× FY 2025
Quick Ratio 2.7×
FY 2021: 0.7×FY 2022: 1.0×FY 2023: 0.9×FY 2024: 0.8×FY 2025: 2.7×
FY 2021 5y median 0.9× FY 2025
Debt / Equity 0.2×
FY 2021: -14.0×FY 2022: 7.7×FY 2023: -7.3×FY 2024: -1.5×FY 2025: 0.2×
FY 2021 5y median -1.5× FY 2025
Net Debt / EBITDA -0.6×
FY 2021: 3.0×FY 2022: 3.1×FY 2023: 23.3×FY 2024: 326×FY 2025: -0.6×
FY 2021 5y median 3.1× FY 2025
Interest Coverage -47.9×
FY 2021: 6.1×FY 2022: 6.9×FY 2023: 0.4×FY 2024: -0.0×FY 2025: -47.9×
FY 2021 5y median 0.4× FY 2025

Dividends

Dividend Yield 0.0%
FY 2021: 0.0%FY 2022: 2.8%FY 2023: 5.4%FY 2024: 0.2%FY 2025: 0.0%
FY 2021 5y median 0.2% FY 2025
Payout Ratio 0.0%
FY 2021: 0.0%FY 2022: 66.8%FY 2023: -966.2%FY 2024: -25.1%FY 2025: 0.0%
FY 2021 5y median 0.0% FY 2025

Annual · latest fiscal year ends 2025-09-30